What to Consider Before Contacting a Venture Capital Investor
Total Page:16
File Type:pdf, Size:1020Kb
Deliverable 6: Network of private investors Background material for AAL project participants March 2014 (updated NHG 15.1.2016) Copyright statement AAL2Business - Report titled “Network of private investors - Background material for AAL project participants“ Report for Ambient Assisted Living Association, Brussels Date April 2014 Author(s) Nordic Healthcare Group Responsible Administrator: AAL Association Brussels Project name: AAL2Business Publisher: Ambient Assisted Living Association Rue de Luxembourg, 3, 2nd floor B-1000 Brussels, Belgium Phone +32 (0)2 219 92 25 email: [email protected] About Ambient Assisted Living Association: The Ambient Assisted Living Association (AALA) is organizing the Ambient Assisted Living Joint Programme (AAL JP). The AAL JP aims at enhancing the quality of life of older people and strengthening the industrial base in Europe through the use of Information and Communication Technologies (ICT). Therefore, the AAL JP is an activity that operates in the field of services and actions to enable the active ageing among the population. The programme is financed by the European Commission and the 22 countries that constitute the Partner States of this Joint Programme. See more at: http://www.aal-europe.eu/ The information and views set out in this report are those of the author(s) and do not necessarily reflect the official opinion of the AALA. The AALA does not guarantee the accuracy of the data included in this study. Neither the AALA nor any person acting on the AALA’s behalf may beheld responsible for the use which may be made of the information contained therein. All rights reserved by AALA. © 2014 Ambient Assisted Living Association, Brussels 2 Contents 1 Introduction and content overview 2 Funding opportunities and availability in Europe 3 Considerations before seeking funding 4 Choosing the right type of funding 5 Investor contacts and event listings • Accelerator Programs & Business angels • Venture capital • Events • Other useful sources 3 Introduction to material . This material has been prepared to aid potential projects in choosing and seeking out the most suitable funding options . First, different sources of equity funding are introduced. Second, different criteria are presented to help choose the best suiting source of funding for each project . Lastly, central Venture Capital companies, local Business Angel networks and organizations, relevant events in Europe and other resources are shortlisted − The shortlist is not exhaustive and serves instead as a potential first place and guideline to start searching for suitable investors − More information and more investors can be found through online searches to complement the provided material − Individual business angels can be targeted efficiently through national or local business angel networks . The material targets startups and early-stage companies . The material concentrates on different forms of equity financing. Debt financing is left out of the scope . All of the companies and organizations presented in the material are based in Europe 4 Overview of material 1. Introduction and overview 3. Considerations before 4. Choosing the right type of 5. Investor contacts and event seeking funding funding listings Introduction to material European Business Angel Networks 5 key Angel Networks shortlisted, in alphabetical order Overview of material The appropriate source of funding depends on the maturity of the Network Region Description Website Phone Email company and the amount of funding required AngelList is a platform connecting startups and AngelList Europe https://angel.co/ [email protected] 1. Introduction and overview 2. Funding opportunities and 3. Choosing the right type of 4. Investor contacts and event investors with country-specific sites availability in Europe funding listings > 10 000 000€1,2 Overview of material The European Trade Association for Business Angels, http://www.eban.or (+32) 2 626 20 Eban Europe [email protected] 1. Introduction and overview Seed Funds and other Early Stage Market Players g/ 62 1 Venture Capital Companies, A network of 400+ business angels looking to invest http://www.envesto +44 (0)20 7240 [email protected]. Private Equity Companies Envestors UK 7 between £20k to £2m in early stage companies rs.co.uk/ 0202 uk 0,8 Gust is a global platform for the sourcing and Gust International http://gust.com/ [email protected] Short introduction to management of early-stage investments Descriptions of funder types presentation and overview of Discussion of available 0,6 Venture Capital Companies, contents. funding and short statistical and suggestions on when each type is appropriate Business Angels The StartAngels Network is a platform for business overview. angel investors StartAngels http://en.startangel Switzerland Our mission is to offer our members access to [email protected] Network s.ch/ 0,4 attractive investment opportunities in early-stage Accelerator Programs, Swiss companies. 5 Amountof funding required Crowdfunding, It should be kept in mind that Business Angels operate more locally than Venture Capital companies, and thus each Listing of key investor 0,2 Early-stage team/entrepreneur interested in Angel Investors should look up their local Angels from AngelList/Eban or the respective networks, funding events and Business Angels other useful resources portals in their home country < 10 000€ 0 29 0Startup 0,5 1 Maturity1,5 of the company2 2,5Established company3 with revenue3,5 7 19 Short introduction to presentation and overview of European Venture Capital companies in the health tech market contents. 20 major VC companies shortlisted, in alphabetical order (1/4) Company Country Description Website Phone Email Advent Venture Partners is one of Europe's most http://www.adventv +44 (0)20 7932 Descriptions of funder types Descriptions of funder types Advent Ventures UK successful growth and venture capital investors in [email protected] entures.com/ 2100 market-leading tech and life sciences businesses. Aescap invests in companies using technologies that The are sufficiently mature to yield realistic product- http://www.aescap. + 31 20 570 29 [email protected] / Aescap Venture and suggestions on when and suggestions on when Netherlands opportunities in combination with the ability to com/ 40 [email protected] 2. Funding opportunities and generate non dilutive financing from licensing deals. Early-stage investor with a focus on enabling technologies and tools which are transforming http://www.ariadne +44 (0)20 3356 Ariadne Capital UK each type is appropriate each type is appropriate established businesses and creating the digital capital.com/ 9690 availability in Europe ecosystem of health and lifestyle BB BIOTECH VENTURES is a healthcare-dedicated venture capital firm. We manage funds (limited http://www.bbbiote +41 44 267 67 BB Biotech Ventures Switzerland partnerships) that invest in private companies [email protected] chventures.com/en/ 00 developing and marketing drugs and medical devices or providing healthcare services. Earlybird invests €200k to €15m in technology Earlybird Venture http://www.earlybir Germany companies that have the potential to impact large +493046724700 [email protected] Capital d.com/ markets. 35 The Life sciences sector is the most common target for Venture Capital investments in EU countries Venture Capital Investments in Europe by Sector Life sciences 28,4 Computer & consumer electronics 19,0 Communications 18,2 Energy & environment 11,0 Consumer goods & retail 5,7 Consumer services 4,8 Listing of key investor Financial services 4,1 Business & industrial products 3,5 Business & industrial services 1,7 Chemicals & materials 1,5 networks, funding events and Transportation 1,1 Construction 0,3 Agriculture 0,3 Real estate 0,2 other useful resources Unclassified 0,1 0,0 5,0 10,0 15,0 20,0 25,0 30,0 % of total VC investments 11 Discussion of available funding and short statistical overview. 5 Contents 1 Introduction and content overview 2 Funding opportunities and availability in Europe 3 Considerations before seeking funding 4 Choosing the right type of funding 5 Investor contacts and event listings • Accelerator Programs & Business angels • Venture capital • Events • Other useful sources 6 The Life sciences sector is the most common target for Venture Capital investments in EU countries Venture Capital Investments in Europe by Sector Life sciences 28,4 Computer & consumer electronics 19,0 Communications 18,2 Energy & environment 11,0 Consumer goods & retail 5,7 Consumer services 4,8 Financial services 4,1 Business & industrial products 3,5 Business & industrial services 1,7 Chemicals & materials 1,5 Transportation 1,1 Construction 0,3 Agriculture 0,3 Real estate 0,2 Unclassified 0,1 0,0 5,0 10,0 15,0 20,0 25,0 30,0 % of total VC investments Source: European Commission 7 European venture capital investments in recent years In 2012, the total VC investments made in the EU summed There are notable differences between VC investments per up to 1,78€bn GDP in EU countries Total investment, €B (bars) Investment as % of GDP (line) VC investment as share of GDP (%) 3,00 0,025 % 2,50 0,020 % 2,00 0,015 % 1,50 2,47 0,010 % 2,24 1,00 1,78 1,75 1,73 1,78 1,75 0,005 % 0,50 0,00 0,000 % 2007 2008 2009 2010 2011 2012 2013 Total VC investment (€M, log scale) Source: European Commission 8 Contents 1 Introduction and content overview 2 Funding opportunities and availability in Europe 3 Considerations before seeking funding 4 Choosing the right type of funding 5 Investor contacts